CMND
Clearmind Medicine Inc. Common Shares
NASDAQ: CMND · HEALTHCARE · BIOTECHNOLOGY
$0.70
-5.61% today
Updated 2026-04-29
Market cap
$1.94M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-24.12
Dividend yield
—
52W range
$1 – $52
Volume
5.8M
Clearmind Medicine Inc. Common Shares (CMND) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-28008.00 | $-39806.00 | $-15371.00 | $-9124.00 | $-80479.00 | $-47851.00 | $-198501.00 | $-2.08M | $-5.06M | $-6.30M | $-6.76M | $-4.73M |
| Capital expenditures | $0.00 | $0.00 | $0.00 | $18422.00 | $99979.00 | $7594.00 | $7506.00 | $169382.00 | $7550.00 | $0.00 | $0.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | — | — | $112273.00 | $0.00 | $0.00 | $619939.00 | $1.64M | $366405.00 | $1.39M | $805815.00 |
| Free cash flow | $-28008.00 | $-39806.00 | $-15371.00 | $-27546.00 | $-180458.00 | $-55445.00 | $-206007.00 | $-2.25M | $-5.06M | $-6.30M | $-6.76M | $-4.73M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — |